Drug-induced mitochondrial dysfunction and cardiotoxicity
Mitochondria has an essential role in myocardial tissue homeostasis; thus deterioration in
mitochondrial function eventually leads to cardiomyocyte and endothelial cell death and …
mitochondrial function eventually leads to cardiomyocyte and endothelial cell death and …
Antineoplastic drug-induced cardiotoxicity: a redox perspective
G Varricchi, P Ameri, C Cadeddu, A Ghigo… - Frontiers in …, 2018 - frontiersin.org
Antineoplastic drugs can be associated with several side effects, including cardiovascular
toxicity (CTX). Biochemical studies have identified multiple mechanisms of CTX …
toxicity (CTX). Biochemical studies have identified multiple mechanisms of CTX …
Cancer therapy–related cardiac dysfunction and heart failure: part 2: prevention, treatment, guidelines, and future directions
CE Hamo, MW Bloom, D Cardinale, B Ky… - Circulation: Heart …, 2016 - Am Heart Assoc
Success with oncologic treatment has allowed cancer patients to experience longer cancer-
free survival gains. Unfortunately, this success has been tempered by unintended and often …
free survival gains. Unfortunately, this success has been tempered by unintended and often …
From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: a translational overview
CG Tocchetti, C Cadeddu, D Di Lisi… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: Antineoplastic therapies have significantly improved the prognosis of oncology
patients. However, these treatments can bring to a higher incidence of side-effects, including …
patients. However, these treatments can bring to a higher incidence of side-effects, including …
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
M Räsänen, J Degerman, TA Nissinen… - Proceedings of the …, 2016 - National Acad Sciences
Congestive heart failure is one of the leading causes of disability in long-term survivors of
cancer. The anthracycline antibiotic doxorubicin (DOX) is used to treat a variety of cancers …
cancer. The anthracycline antibiotic doxorubicin (DOX) is used to treat a variety of cancers …
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy
C Madeddu, M Deidda, A Piras… - Journal of …, 2016 - journals.lww.com
The risk and mechanism of chemotherapy-induced cardiotoxicity (CTX) vary depending on
the type and intensity of the anticancer regimen. Myriad chemotherapeutic drugs produce …
the type and intensity of the anticancer regimen. Myriad chemotherapeutic drugs produce …
The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and …
Due to its poor capacity for regeneration, the heart is particularly sensitive to the loss of
contractile cardiomyocytes. The onslaught of damage caused by ischaemia and reperfusion …
contractile cardiomyocytes. The onslaught of damage caused by ischaemia and reperfusion …
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research‐practice gaps, challenges, and insights
PP Zheng, J Li, JM Kros - Medicinal research reviews, 2018 - Wiley Online Library
To date, five cancer treatment modalities have been defined. The three traditional modalities
of cancer treatment are surgery, radiotherapy, and conventional chemotherapy, and the two …
of cancer treatment are surgery, radiotherapy, and conventional chemotherapy, and the two …
Update on pathophysiology and preventive strategies of anthracycline‐induced cardiotoxicity
R Corremans, R Adão… - Clinical and …, 2019 - Wiley Online Library
Anthracycline chemotherapy has a prominent role in treating many forms of cancer.
Unfortunately, cardiotoxic side effects represent a serious limitation to their use, with …
Unfortunately, cardiotoxic side effects represent a serious limitation to their use, with …
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
M Camilli, M Viscovo, L Maggio, A Bonanni… - Basic Research in …, 2024 - Springer
Sodium–glucose cotransporter 2 inhibitors (SGLT2i), a new drug class initially designed and
approved for treatment of diabetes mellitus, have been shown to exert pleiotropic metabolic …
approved for treatment of diabetes mellitus, have been shown to exert pleiotropic metabolic …